Clinical trial
Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in…
NCT00095355 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00095355 |
|---|---|
| Title | Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease |
| Official title | Stimulation of Tyrosine Kinase and ERK Signaling Pathways in Huntington's Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Huntington's Disease |
| Intervention type | Drug |
| Interventions | Lithium, Divalproex |
| Enrollment | 35 |
| Start date | Oct 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Nov 3, 2004 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: